These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1781380)

  • 41. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction.
    Silva PH; Dillon D; Van Wylen DG
    Cardiovasc Res; 1995 May; 29(5):616-23. PubMed ID: 7606748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chondroosseous histopathology in adenosine deaminase deficient combined immunodeficiency disease.
    Kaitila I; Rimoin DL; Cedarbaum SD; Stiehm ER; Lachman RS
    Birth Defects Orig Artic Ser; 1976; 12(6):115-21. PubMed ID: 974246
    [No Abstract]   [Full Text] [Related]  

  • 43. Adenosine and deoxyadenosine metabolism in the erythrocytes of a patient with adenosine deaminase deficiency.
    Sahota A; Simmonds HA; Potter CF; Watson JG; Hugh-Jones K; Perrett D
    Adv Exp Med Biol; 1980; 122A():397-401. PubMed ID: 6999851
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
    Carson DA; Iizasa T; Seto S; Carrera CJ; Kubota M; Willis EH; Wasson DB; Kajander O
    Ann N Y Acad Sci; 1985; 451():34-41. PubMed ID: 3878120
    [No Abstract]   [Full Text] [Related]  

  • 46. Cytotoxicity of deoxycoformycin on human colon carcinoma cell lines.
    Camici M; Turriani M; Turchi G; Tozzi MG; Cos J; Alemany C; Noe V; Ciudad CJ
    Adv Exp Med Biol; 1994; 370():275-8. PubMed ID: 7660907
    [No Abstract]   [Full Text] [Related]  

  • 47. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
    Ozdemir O
    Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
    Hershfield MS
    Eur J Immunol; 2005 Jan; 35(1):25-30. PubMed ID: 15580654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry.
    Xu Y; Venton BJ
    Phys Chem Chem Phys; 2010 Sep; 12(34):10027-32. PubMed ID: 20577678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors.
    Golembiowska K; White TD; Sawynok J
    Brain Res; 1995 Nov; 699(2):315-20. PubMed ID: 8616636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Niacin prevents DNA strand breakage by adenosine deaminase inhibitors.
    Weitberg AB; Corvese D
    Biochem Biophys Res Commun; 1990 Mar; 167(2):514-9. PubMed ID: 2322239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inability of poly-ADP-ribosylation inhibitors to protect peripheral blood lymphocytes from the toxic effects of ADA inhibition.
    Ganeshaguru K; Piga A; Latini L; Hoffbrand AV
    Adv Exp Med Biol; 1989; 253B():251-8. PubMed ID: 2532859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered deoxynucleoside triphosphate levels paralleling deoxyadenosine toxicity in adenosine deaminase inhibited human lymphocytes.
    Bluestein HG; Thompson LF; Albert DA; Seegmiller JE
    Adv Exp Med Biol; 1980; 122A():427-31. PubMed ID: 6968502
    [No Abstract]   [Full Text] [Related]  

  • 57. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
    J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purine metabolism by guinea-pig ileum.
    Webster DR; Boston G; Paton DM
    Adv Exp Med Biol; 1986; 195 Pt B():19-28. PubMed ID: 3490118
    [No Abstract]   [Full Text] [Related]  

  • 59. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

  • 60. Defects in the growth plate of brachypodism in mice--light and electron microscopic findings and cell proliferation by the method of tritiated thymidine autoradiography.
    Nakamura K; Hirosawa K; Hama K; Oda S
    Nihon Seikeigeka Gakkai Zasshi; 1984 Aug; 58(8):835-45. PubMed ID: 6501989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.